HS code: 30
Country | |
Direction | |
Country | |
Period | |
Selection products |
Period | Total |
---|---|
2020 | $130 M |
Total: | $130 M |
Period | Weight, tons. |
---|---|
2020 | 881 |
Total: | 881 |
Group product | 2020 | 2020 | Ch. | ∑ (2020-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $802 | $802 | 0% | $802 | 0% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | $114 K | $114 K | 0% | $114 K | 0.1% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $130 M | $130 M | 0% | $130 M | 99.9% |
06 3005: Wadding, gauze, bandages and similar articles | $44.2 K | $44.2 K | 0% | $44.2 K | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $130 M | $130 M | $130 M |
№ | Country | ∑ (2020-2020) | Ratio |
---|---|---|---|
1 | Germany | $2.08 B | 17.6% |
2 | United States | $989 M | 8.4% |
3 | Italy | $803 M | 6.8% |
4 | Switzerland | $792 M | 6.7% |
5 | Ireland | $716 M | 6% |
6 | France | $577 M | 4.9% |
7 | India | $508 M | 4.3% |
8 | Belarus | $339 M | 2.9% |
9 | Slovenia | $322 M | 2.7% |
10 | United Kingdom | $317 M | 2.7% |
11 | Hungary | $299 M | 2.5% |
12 | Netherlands | $293 M | 2.5% |
13 | Austria | $283 M | 2.4% |
14 | China | $273 M | 2.3% |
15 | Spain | $227 M | 1.9% |
... | ... | ... | ... |
22 | Japan | $138 M | 1.2% |
23 | Poland | $133 M | 1.1% |
24 | Romania | $130 M | 1.1% |
25 | South Korea | $123 M | 1% |
26 | Denmark | $112 M | 0.9% |
... | ... | ... | ... |
The total for all countries: | $11.8 B | 100% |
№ | Region | ∑ (2020-2020) | Ratio |
---|---|---|---|
1 | Moskva | $118 M | 90.5% |
2 | Moskovskaya oblast | $12.2 M | 9.4% |
3 | Nijegorodskaya oblast | $68 K | 0.1% |
4 | Ivanovskaya oblast | $44.2 K | 0% |
5 | Kalujskaya oblast | $2.01 K | 0% |
6 | Novosibirskaya oblast | $802 | 0% |
By all regions: | $130 M | 100% |